Corporate Banner
Satellite Banner
Technology Networks Header
Friday, July 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology
Thursday, July 24, 2014
MuDT™ technology doubles the channel availability of any real-time PCR instrument.

Bio-Rad Introduces SsoAdvanced™ Universal Inhibitor-Tolerant SYBR®Green Supermix
Tuesday, July 15, 2014
New reagent delivers quality qPCR data from samples that are challenging to amplify.

QC Labs Selects Bio-Rad’s iQ-Check® Prep Automation Solution for Food Pathogen Detection
Friday, July 11, 2014
Independent food testing laboratory, QC Laboratories has selected Bio-Rad’s iQ-Check Prep Automation Solution for detecting foodborne pathogens.

Bio-Rad Launches New Reagents for Target-Specific Preamplification of Limited Templates for Real-Time PCR
Tuesday, June 10, 2014
Bio-Rad Laboratories, Inc. announced the launch of its SsoAdvanced™ PreAmp Supermix and PrimePCR™ PreAmp Assays.

New 20µl Liquidator 96 from Anachem
Thursday, May 22, 2014
Maximizes users workflow with fast, 96-well pipetting and no complex programming.

Bio-Rad Expands Portfolio of PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, May 21, 2014
Company expands its collection of validated assays for mutation detection and copy number variation.

Compact Ozone Sterilizer Eliminates Contaminants and Germs
Saturday, May 17, 2014
Ozilla™ - A new high quality, purpose-built ozone gas generator from AMSBIO.

Agilent Technologies Introduces New SureDirect Blood PCR Kit
Saturday, May 17, 2014
Enables PCR directly from blood without nucleic acid extraction.

Salmonella Species PCR Assay Offers Validated Method for Fast, Simple Detection of Food Pathogens
Friday, May 16, 2014
The NF validation certificate granted by AFNOR Certification for the SureTect Salmonella Species Real-Time PCR Assay.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 576
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv